Literature DB >> 7350459

Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

H Heath, S F Hodgson, M A Kennedy.   

Abstract

We examined the incidence and clinical and economic consequences of primary hyperparathyroidism in residents of Rochester, Minn, from 1965 through 1976; 90 cases were found. From January 1, 1965, to June 31, 1974, the average annual incidence was 7.8 +/- 1.2 (mean +/- S.D.) cases per 100,000 population. However, after the introduction of routine measurement of serum calcium, the average annual incidence rose to 51.1 +/- 9.6 cases per 100,000. Even after availability of routine measurement of serum calcium, the annual incidence of primary hyperparathyroidism among persons 39 years of age or younger remained below 10 cases per 100,000. However, the annual incidence increased sharply in persons 40 or more years of age, reaching 188 cases per 100,000 among women 60 years of age and over and 92 cases per 100,000 among men 60 and over. For the last 1.5 years of the study, the average annual age-adjusted incidence of primary hyperparathyroidism was 27.7 +/- 5.8 per 100,000. The frequency of urolithiasis fell from 51 to 4 per cent (P less than 0.001), and the proportion of cases without symptoms or complications of primary hyperparathyroidism rose from 18 to 51 per cent (P less than 0.005). The median charge in 1977 for diagnosis and treatment of primary hyperparathyroidism was $1700. (N Engl J Med 302:189-193, 1980).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350459     DOI: 10.1056/NEJM198001243020402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  146 in total

1.  Rare presentation of maternal primary hyperparathyroidism.

Authors:  G C Beattie; N R Ravi; M Lewis; H Williams; A W Blair; I W Campbell; G G Browning
Journal:  BMJ       Date:  2000-07-22

Review 2.  Clinical spectrum of primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

3.  West Germany: still an underdeveloped country in the diagnosis and early treatment of primary hyperparathyroidism?

Authors:  C Dotzenrath; P E Goretzki; H D Röher
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

4.  Anesthesia and hyperparathyroidism.

Authors:  Takahiko Okuda; Motoko Oiki; Yasunori Shiokawa; Osamu Kumode; Keita Suekane
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

5.  Minimally invasive parathyroidectomy.

Authors:  F Fausto Palazzo; Gregory P Sadler
Journal:  BMJ       Date:  2004-04-10

6.  Parathyroid lesions: characterization with dual-phase arterial and venous enhanced CT of the neck.

Authors:  A R Gafton; C M Glastonbury; J D Eastwood; J K Hoang
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

Review 7.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

8.  The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism.

Authors:  N Glynn; N Lynn; C Donagh; R K Crowley; D Smith; C J Thompson; A D K Hill; F Keeling; A Agha
Journal:  Ir J Med Sci       Date:  2010-11-13       Impact factor: 1.568

9.  Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  Bone       Date:  2014-12-11       Impact factor: 4.398

10.  Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.

Authors:  D Scarpelli; L D'Aloiso; F Arturi; A Scillitani; I Presta; M Bisceglia; C Cristofaro; D Russo; S Filetti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.